Corporate & Investor Presentation
Propeller Health: Digital health solutions for inhaled COPD
and asthma medications
Establishes ResMed as a leading provider of COPD and asthma patient
management solutions
Uses FDA-cleared sensors with inhalers and a consumer app to track
medication usage, provide insights to patients, and access to clinical data
for physician monitoring
•
•
ResMed now has end-to-end digital health solutions for COPD
patients across multiple stages of the disease and continuum of care
Enables Propeller to deliver value to patients, caregivers, providers,
payers, pharmaceutical companies, and other healthcare
organizations
Contracts with pharma companies to
support clinical trials and biologics
LIFE SCIENCES
gsk
(1)
NOVARTIS
ORION
($$
Patients + $$
Increased drug
adherence and sales
Improved clinical trial
speed and enhanced time
to market
49 2022 ResMed | Corporate & Investor Presentation - updated 28APR22
Health and economic
outcomes
Direct and value-based contracts with
health systems and payers
HEALTHCARE
Payers
Top 50 Payers
Propeller
PBMs
EXPRESS SCRIPTS
Clinical insights and
efficiencies
Health
systems
Dignity Health.
Patient Engagement
$$
Patients + $$
Pharmacies Walgreens
ResMedView entire presentation